Narrative review / 2019
Nicotinamide reduces transepidermal water loss and new non-melanoma skin cancers in high-risk humans.
This review examines the dermatologic roles of nicotinamide, a water-soluble vitamin B3 derivative, specifically for preventing photoaging and skin cancers. Nicotinamide prevents UV-induced ATP depletion and glycolysis inhibition, thereby enhancing DNA repair and lowering UV-induced immune suppression. Randomized controlled clinical trials noted in the review demonstrate that nicotinamide decreases transepidermal water loss and the occurrence of new non-melanoma skin cancers in high-risk humans.
- Study type
- Narrative review
- Who was studied
- Humans, including those at high risk of skin cancers
- What was measured
- Photoaging, skin cancer development, transepidermal water loss, safety
THE PAPER
Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.
Snaidr VA, Damian DL, Halliday GM. Exp Dermatol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.